作者
Maria Lopez-Santillan, Ane Larrabeiti-Etxebarria, Javier Arzuaga-Mendez, Elixabet Lopez-Lopez, Africa Garcia-Orad
发表日期
2018/4/4
来源
Oncotarget
卷号
9
期号
32
页码范围
22850
出版商
Impact Journals, LLC
简介
Diffuse large B-cell lymphoma (DLBCL) is an aggressive and heterogeneous malignancy, with highly variable outcomes among patients. Although classification and prognostic tools have been developed, standard therapy still fails in 30-40% of patients. Hence, identification of novel biomarkers is needed. Recently, circulating microRNAs (miRNAs) have been suggested as non-invasive biomarkers in cancer. Our aim was to review the potential role of circulating miRNAs as biomarkers for diagnosis, classification, prognosis, and treatment response in DLBCL.
学术搜索中的文章
M Lopez-Santillan, A Larrabeiti-Etxebarria… - Oncotarget, 2018